October 26, 2006 Merck / Johnson & Johnson/ Lilly-Zyprexa: $690 Million settlement / a Flowering of Diabetes DrugsMerck / Johnson & Johnson/ Lilly-Zyprexa: $690 Million settlement / a Flowering of Diabetes Drugs Fri, 10 Read More Merck / Johnson & Johnson/ Lilly-Zyprexa: $690 Million settlement / a Flowering of Diabetes Drugs
October 26, 2006 Mosholder Suppressed Report Posted/ Bush Moves to Block Medical Suits – NYTMosholder Suppressed Report Posted/ Bush Moves to Block Medical Suits – NYT Mon, 26 Jul 2004 The Read More Mosholder Suppressed Report Posted/ Bush Moves to Block Medical Suits – NYT
October 26, 2006 FDA Underhanded Tactics Against Medical Officer Who Blew the WhistleFDA Underhanded Tactics Against Medical Officer Who Blew the Whistle Mon, 29 Nov 2004 The Food and Read More FDA Underhanded Tactics Against Medical Officer Who Blew the Whistle
October 26, 2006 How Did the Vioxx Debacle Happen? USA Today / LancetHow Did the Vioxx Debacle Happen? USA Today / Lancet Tue, 12 Oct 2004 Dr. Eric Topol Read More How Did the Vioxx Debacle Happen? USA Today / Lancet
October 26, 2006 Trial Lawyers Are Taking Aim at the Drug Industry_NYTTrial Lawyers Are Taking Aim at the Drug Industry_NYT Sun, 18 May 2003 It appears that trial Read More Trial Lawyers Are Taking Aim at the Drug Industry_NYT
January 14, 2006 S. Finance Committee Investigates Drug Makers Over Medical Education Grants_NYTSuch payments are, in fact, kick backs for these groups’ promotional services encouraging doctors to prescribe drugs Read More S. Finance Committee Investigates Drug Makers Over Medical Education Grants_NYT
September 12, 2005 Abbott Seeks FDA approval for cancer drug despite failed trials – WSJAbbott Seeks FDA approval for cancer drug despite failed trials – WSJ Mon, 12 Sep 2005 Abbott Read More Abbott Seeks FDA approval for cancer drug despite failed trials – WSJ
July 18, 2005 2005: “Cheaper than Chimpanzees” by Vera SharavTHE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) www.ahrp.org CHEAPER THAN CHIMPANZEES Statement Presented By VERA HASSNER SHARAV Read More 2005: “Cheaper than Chimpanzees” by Vera Sharav
June 10, 2005 Lucrative Drug, Danger Signals and the F.D.A. – NY Timeshttp://www.nytimes.com/2005/06/10/business/10drug.html?ei=5094&en=5475b3c17e50e692&hp =&ex=1118462400&partner=homepage&pagewanted=print THE NEW YORK TIMES June 10, 2005, front page Lucrative Drug, Danger Signals and the Read More Lucrative Drug, Danger Signals and the F.D.A. – NY Times
August 18, 2003 Best Pharmaceuticals for Children Act of 2002Comments submitted by The Alliance for Human Research Protection The National Academy of Sciences Committee of the Read More Best Pharmaceuticals for Children Act of 2002
January 15, 2003 References: Impact of FDA inclusion of children as test subjectsReferences for THE IMPACT OF THE FDA MODERNIZATION ACT ON THE RECRUITMENT OF CHILDREN FOR RESEARCH Vera Read More References: Impact of FDA inclusion of children as test subjects
May 14, 2002 Dissenting Opinion – Proposed Children’s Workgroup Reinterpretation of Fed Regs 45 CFR 46 sects. 404 & 406Dissenting Opinion (NHRPAC Children Workgroup) re: Proposed Reinterpretation of Fed. Regs Protecting Children (45 CFR 46, sections Read More Dissenting Opinion – Proposed Children’s Workgroup Reinterpretation of Fed Regs 45 CFR 46 sects. 404 & 406
May 7, 2002 Conflicts of Interest in Clinical TrialsPresented by Vera Hassner Sharav 14th Tri-Service Clinical Investigation Symposium Sponsored by The U.S. Army Medical Department Read More Conflicts of Interest in Clinical Trials
May 5, 2002 Sharav Presentation before US Army Medical Dept., May 6, 2002CONFLICTS OF INTEREST Presented by Vera Hassner Sharav 14th TRI-SERVICE CLINICAL INVESTIGATION SYMPOSIUM Sponsored By THE U.S. Read More Sharav Presentation before US Army Medical Dept., May 6, 2002